Picture of Dice Therapeutics logo

DICE — Dice Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: Dice Therapeutics Reports Q1 Loss Per Share Of $0.50

May 12 (Reuters) - Dice Therapeutics Inc  DICE.O :
    * DICE THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
    * DICE THERAPEUTICS INC - QTRLY NET LOSS TOTALED $18.6
MILLION
    * DICE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.50
    * DICE THERAPEUTICS INC - CURRENT CASH PROVIDES RUNWAY
THROUGH
MID-2024

Further company coverage:  DICE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Dice Therapeutics

See all news